Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1003

1.

Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.

Mann JA, Abraham WT.

Curr Heart Fail Rep. 2019 Feb 14. doi: 10.1007/s11897-019-0422-3. [Epub ahead of print] Review.

PMID:
30762177
2.

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.

Dewan P, Rørth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Køber L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators.

JACC Heart Fail. 2019 Feb 4. pii: S2213-1779(18)30839-4. doi: 10.1016/j.jchf.2018.11.005. [Epub ahead of print]

3.

Electrophysiological Investigation of Metabotropic Glutamate Receptor-Dependent Metaplasticity in the Hippocampus.

Hegemann RU, Abraham WC.

Methods Mol Biol. 2019;1941:79-91. doi: 10.1007/978-1-4939-9077-1_7.

PMID:
30707429
4.

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.

Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV.

J Am Coll Cardiol. 2019 Jan 8;73(1):29-40. doi: 10.1016/j.jacc.2018.09.081.

5.

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO-VAD pilot study.

Veenis JF, Manintveld OC, Constantinescu AA, Caliskan K, Birim O, Bekkers JA, van Mieghem NM, den Uil CA, Boersma E, Lenzen MJ, Zijlstra F, Abraham WT, Adamson PB, Brugts JJ.

ESC Heart Fail. 2019 Feb;6(1):194-201. doi: 10.1002/ehf2.12392. Epub 2019 Jan 7.

6.

A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience.

Perl L, Soifer E, Bartunek J, Erdheim D, Köhler F, Abraham WT, Meerkin D.

J Cardiovasc Transl Res. 2019 Jan 2. doi: 10.1007/s12265-018-9856-3. [Epub ahead of print]

PMID:
30604310
7.

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.

Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV.

Eur J Heart Fail. 2018 Dec 10. doi: 10.1002/ejhf.1347. [Epub ahead of print]

PMID:
30536678
8.

Genetic targeting and chemogenetic inhibition of new born neurons.

Schoderboeck L, Wicky HE, Abraham WC, Hughes S.

Hum Gene Ther Methods. 2018 Dec 7. doi: 10.1089/hgtb.2018.182. [Epub ahead of print]

PMID:
30526082
9.

Ambulatory Fontan pressure monitoring: Results from the implantable hemodynamic monitor Fontan feasibility cohort (IHM-FFC).

Bradley EA, Jassal A, Moore-Clingenpeel M, Abraham WT, Berman D, Daniels CJ.

Int J Cardiol. 2018 Oct 28. pii: S0167-5273(18)34059-2. doi: 10.1016/j.ijcard.2018.10.081. [Epub ahead of print]

PMID:
30420147
10.

Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.

Rodés-Cabau J, Bernier M, Amat-Santos IJ, Ben Gal T, Nombela-Franco L, García Del Blanco B, Kerner A, Bergeron S, Del Trigo M, Pibarot P, Shkurovich S, Eigler N, Abraham WT.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2300-2310. doi: 10.1016/j.jcin.2018.07.001. Epub 2018 Nov 1.

PMID:
30391390
11.

Cytochalasans Act as Inhibitors of Biofilm Formation of Staphylococcus Aureus.

Yuyama KT, Wendt L, Surup F, Kretz R, Chepkirui C, Wittstein K, Boonlarppradab C, Wongkanoun S, Luangsa-Ard J, Stadler M, Abraham WR.

Biomolecules. 2018 Oct 30;8(4). pii: E129. doi: 10.3390/biom8040129.

12.

Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.

Parikh KS, Fiuzat M, Davis G, Neely M, Blain-Nelson P, Whellan DJ, Abraham WT, Adams KF Jr, Felker GM, Liggett SB, O'Connor CM, Bristow MR.

Circ Genom Precis Med. 2018 Aug;11(8):e002210. doi: 10.1161/CIRCGEN.117.002210.

PMID:
30354340
13.

Circulating Plasma microRNAs are Altered with Amyloidosis in a Mouse Model of Alzheimer's Disease.

Ryan MM, Guévremont D, Mockett BG, Abraham WC, Williams JM.

J Alzheimers Dis. 2018;66(2):835-852. doi: 10.3233/JAD-180385.

PMID:
30347618
14.

Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure.

Costanzo MR, Ponikowski P, Coats A, Javaheri S, Augostini R, Goldberg LR, Holcomb R, Kao A, Khayat RN, Oldenburg O, Stellbrink C, McKane S, Abraham WT; remedē® System Pivotal Trial Study Group.

Eur J Heart Fail. 2018 Dec;20(12):1746-1754. doi: 10.1002/ejhf.1312. Epub 2018 Oct 10.

PMID:
30303611
15.

Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators.

N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23.

PMID:
30280640
16.

From Synaptic Metaplasticity to Behavioral Metaplasticity.

Abraham WC, Richter-Levin G.

Neurobiol Learn Mem. 2018 Oct;154:1-4. doi: 10.1016/j.nlm.2018.08.015. No abstract available.

PMID:
30217268
17.

Environmental enrichment increases prefrontal EEG power and synchrony with the hippocampus in rats with anterior thalamus lesions.

Ulrich K, Spriggs MJ, Abraham WC, Dalrymple-Alford JC, McNaughton N.

Hippocampus. 2019 Feb;29(2):128-140. doi: 10.1002/hipo.23022. Epub 2018 Nov 22.

PMID:
30153381
18.

Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.

Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW.

Am Heart J. 2018 Nov;205:1-11. doi: 10.1016/j.ahj.2018.07.021. Epub 2018 Aug 1.

PMID:
30134187
19.

First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.

Zile MR, Abraham WT, Lindenfeld J, Weaver FA, Zannad F, Graves T, Rogers T, Galle EG.

Am Heart J. 2018 Oct;204:139-150. doi: 10.1016/j.ahj.2018.07.011. Epub 2018 Jul 22.

20.

Family health and income: A two-sample replication.

Schofield TJ, Robins RW, Fox J, Abraham WT, Cutrona C.

J Fam Psychol. 2018 Aug;32(5):632-642. doi: 10.1037/fam0000424. Epub 2018 Jul 12.

PMID:
29999344
21.

Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability.

Moynihan KD, Holden RL, Mehta NK, Wang C, Karver MR, Dinter J, Liang S, Abraham W, Melo MB, Zhang AQ, Li N, Gall SL, Pentelute BL, Irvine DJ.

Cancer Immunol Res. 2018 Sep;6(9):1025-1038. doi: 10.1158/2326-6066.CIR-17-0607. Epub 2018 Jun 18.

PMID:
29915023
22.

Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF.

Abraham WT, Pleister A, Germany R.

Card Fail Rev. 2018 May;4(1):50-53. doi: 10.15420/cfr.2018:9:1. Review.

23.

Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.

Varma N, Sogaard P, Bax JJ, Abraham WT, Borer JS, Dickstein K, Singh JP, Gras D, Holzmeister J, Brugada J, Ruschitzka F.

J Am Heart Assoc. 2018 May 27;7(11). pii: e009592. doi: 10.1161/JAHA.118.009592. Erratum in: J Am Heart Assoc. 2018 Jun 17;7(12):.

24.

The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.

Raval AN, Cook TD, Duckers HJ, Johnston PV, Traverse JH, Abraham WT, Altman PA, Pepine CJ.

Am Heart J. 2018 Jul;201:141-148. doi: 10.1016/j.ahj.2018.03.016. Epub 2018 Apr 3.

PMID:
29803986
25.

Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

Bergin DH, Jing Y, Mockett BG, Zhang H, Abraham WC, Liu P.

Transl Psychiatry. 2018 May 25;8(1):108. doi: 10.1038/s41398-018-0149-z.

26.

Adult-born dentate granule cell excitability depends on the interaction of neuron age, ontogenetic age and experience.

Ohline SM, Wake KL, Hawkridge MV, Dinnunhan MF, Hegemann RU, Wilson A, Schoderboeck L, Logan BJ, Jungenitz T, Schwarzacher SW, Hughes SM, Abraham WC.

Brain Struct Funct. 2018 Sep;223(7):3213-3228. doi: 10.1007/s00429-018-1685-2. Epub 2018 May 23.

PMID:
29796923
27.

The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study.

Senfield J, Daubert C, Abraham WT, Ghio S, St John Sutton M, Cerkvenik J, Linde C, Gold MR.

JACC Clin Electrophysiol. 2017 Aug;3(8):818-826. doi: 10.1016/j.jacep.2017.01.017. Epub 2017 Apr 26.

28.

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.

Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G.

JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10.

29.

A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.

Piccini JP, Connolly SJ, Abraham WT, Healey JS, Steinberg BA, Al-Khalidi HR, Dignacco P, van Veldhuisen DJ, Sauer WH, White M, Wilton SB, Anand IS, Dufton C, Marshall DA, Aleong RG, Davis GW, Clark RL, Emery LL, Bristow MR.

Am Heart J. 2018 May;199:51-58. doi: 10.1016/j.ahj.2017.12.001. Epub 2017 Dec 6.

PMID:
29754666
30.

Sustained 12 Month Benefit of Phrenic Nerve Stimulation for Central Sleep Apnea.

Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg LR, Holcomb R, Kao A, Khayat RN, Oldenburg O, Stellbrink C, Abraham WT; remedē System Pivotal Trial Study Group.

Am J Cardiol. 2018 Jun 1;121(11):1400-1408. doi: 10.1016/j.amjcard.2018.02.022. Epub 2018 Apr 20.

31.

Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women's Health Initiative.

Breathett K, Leng I, Foraker RE, Abraham WT, Coker L, Whitfield KE, Shumaker S, Manson JE, Eaton CB, Howard BV, Ijioma N, Cené CW, Martin LW, Johnson KC, Klein L.

Circ Heart Fail. 2018 May;11(5):e004642. doi: 10.1161/CIRCHEARTFAILURE.117.004642.

PMID:
29716899
32.

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Müller-Ehmsen J.

Int J Cardiol. 2018 Sep 1;266:187-192. doi: 10.1016/j.ijcard.2018.04.075. Epub 2018 Apr 21.

PMID:
29705650
33.

De Novo Fatty Acid Synthesis During Mycobacterial Infection Is a Prerequisite for the Function of Highly Proliferative T Cells, But Not for Dendritic Cells or Macrophages.

Stüve P, Minarrieta L, Erdmann H, Arnold-Schrauf C, Swallow M, Guderian M, Krull F, Hölscher A, Ghorbani P, Behrends J, Abraham WR, Hölscher C, Sparwasser TD, Berod L.

Front Immunol. 2018 Apr 5;9:495. doi: 10.3389/fimmu.2018.00495. eCollection 2018.

34.

Environmental enrichment effects on synaptic and cellular physiology of hippocampal neurons.

Ohline SM, Abraham WC.

Neuropharmacology. 2019 Feb;145(Pt A):3-12. doi: 10.1016/j.neuropharm.2018.04.007. Epub 2018 Apr 7. Review.

PMID:
29634984
35.

Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.

Tayal B, Gorcsan J 3rd, Bax JJ, Risum N, Olsen NT, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Krum H, Brugada J, Robertson M, Ford I, Holzmeister J, Ruschitzka F, Sogaard P.

J Am Coll Cardiol. 2018 Mar 27;71(12):1325-1333. doi: 10.1016/j.jacc.2018.01.042.

PMID:
29566816
36.

Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education.

Breathett K, Maffett S, Foraker RE, Sturdivant R, Moon K, Hasan A, Franco V, Smith S, Lampert BC, Emani S, Haas G, Kahwash R, Hershberger RE, Binkley PF, Helmkamp L, Colborn K, Peterson PN, Sweitzer N, Abraham WT.

Am J Med. 2018 Aug;131(8):974-978. doi: 10.1016/j.amjmed.2018.02.017. Epub 2018 Mar 16.

PMID:
29555457
37.

Neighborhood racial discrimination and the development of major depression.

Russell DW, Clavél FD, Cutrona CE, Abraham WT, Burzette RG.

J Abnorm Psychol. 2018 Feb;127(2):150-159. doi: 10.1037/abn0000336.

38.

Microporenic Acids A-G, Biofilm Inhibitors, and Antimicrobial Agents from the Basidiomycete Microporus Species.

Chepkirui C, Yuyama KT, Wanga LA, Decock C, Matasyoh JC, Abraham WR, Stadler M.

J Nat Prod. 2018 Apr 27;81(4):778-784. doi: 10.1021/acs.jnatprod.7b00764. Epub 2018 Feb 28.

PMID:
29489350
39.

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.

Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R.

Eur J Heart Fail. 2018 May;20(5):888-895. doi: 10.1002/ejhf.1146. Epub 2018 Feb 28.

40.

Long-term potentiation expands information content of hippocampal dentate gyrus synapses.

Bromer C, Bartol TM, Bowden JB, Hubbard DD, Hanka DC, Gonzalez PV, Kuwajima M, Mendenhall JM, Parker PH, Abraham WC, Sejnowski TJ, Harris KM.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2410-E2418. doi: 10.1073/pnas.1716189115. Epub 2018 Feb 20.

41.

Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease.

Tan VTY, Mockett BG, Ohline SM, Parfitt KD, Wicky HE, Peppercorn K, Schoderboeck L, Yahaya MFB, Tate WP, Hughes SM, Abraham WC.

Mol Brain. 2018 Feb 9;11(1):7. doi: 10.1186/s13041-018-0348-9.

42.

Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.

O'Connor CM, Psotka MA, Fiuzat M, Lindenfeld J, Abraham WT, Bristow MR, Canos D, Harrington RA, Hillebrenner M, Jessup M, Malik FI, Solomon SD, Stockbridge N, Tcheng JE, Unger EF, Whellan DJ, Zuckerman B, Califf RM.

J Am Coll Cardiol. 2018 Jan 30;71(4):443-453. doi: 10.1016/j.jacc.2017.11.048. Review.

43.

The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis.

Linde C, Cleland JGF, Gold MR, Claude Daubert J, Tang ASL, Young JB, Sherfesee L, Abraham WT.

Eur J Heart Fail. 2018 Apr;20(4):780-791. doi: 10.1002/ejhf.1133. Epub 2018 Jan 4. Review.

44.

Intergenerational continuity in attitudes: A latent variable family fixed-effects approach.

Schofield TJ, Abraham WT.

J Fam Psychol. 2017 Dec;31(8):1005-1016. doi: 10.1037/fam0000375.

PMID:
29309186
45.

Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K).

Kumar S, Abowd G, Abraham WT, al'Absi M, Chau DHP, Ertin E, Estrin D, Ganesan D, Hnat T, Hossain SM, Ives Z, Kerr J, Marlin BM, Murphy S, Rehg JM, Nahum-Shani I, Shetty V, Sim I, Spring B, Srivastava M, Wetter D.

IEEE Pervasive Comput. 2017 Apr-Jun;16(2):18-22. doi: 10.1109/MPRV.2017.29. Epub 2017 Apr 3. No abstract available.

46.

Bioactive Compounds Produced by Hypoxylon fragiforme against Staphylococcus aureus Biofilms.

Yuyama KT, Chepkirui C, Wendt L, Fortkamp D, Stadler M, Abraham WR.

Microorganisms. 2017 Dec 12;5(4). pii: E80. doi: 10.3390/microorganisms5040080.

47.

Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey.

Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P; INI-CRCT, Great Network, and the EF-HF Group.

JACC Heart Fail. 2018 Apr;6(4):273-285. doi: 10.1016/j.jchf.2017.09.023. Epub 2017 Dec 6. Review.

PMID:
29226815
48.

Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.

Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators and Committees.

J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027.

49.

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.

Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators and Committees.

Circ Heart Fail. 2017 Nov;10(11). pii: e004361. doi: 10.1161/CIRCHEARTFAILURE.117.004361.

PMID:
29141857
50.

Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials.

Nassif ME, Tang Y, Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Daubert JC, Sherfesee L, Schaber D, Tang ASL, Jones PG, Arnold SV, Spertus JA.

Circ Heart Fail. 2017 Oct;10(10). pii: e004111. doi: 10.1161/CIRCHEARTFAILURE.117.004111.

Supplemental Content

Loading ...
Support Center